NAS10029,813+0.55%S&P7,744+0.28%GOLD$4,048−0.09%BTC$79,778−1.83%VIX16.91−3.48%latest tape · as of 07:18 UTC
The Screen · Consumer Cyclical · Auto Parts
Allison Transmission Holdings, Inc.
ALSN · the NYSE · USD · Market cap $9.1B · 4,000 employees
Allison Transmission Holdings, Inc., together with its subsidiaries, designs, manufactures, and sells fully automatic transmissions for medium- and heavy-duty commercial vehicles and medium- and heavy-tactical U.S.
FAIL · Does not pass the screen
107.67 USD
Price as of 27 Oct 2026Daily close, not a live quote
Screened 2026-10-27 · the tape above runs as of 07:18 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price107.67 USD at the 27 Oct 2026 close
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.63)
Last reviewed27 Oct 2026 (2 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 107.67 against the desk's fair-value range, base estimate 168.75, over the last year.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.63, read 2026-10-24
Ethical does not pass the values gate
Price107.67 USD
Fair value168.75
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Markdown116.28-7.4% to today ✓Distribution gives way to Markdown after an 8% slide in 11 days
2026-09-21Read Distribution126.94-15.2% to today ✓Markup gives way to Distribution after a 9% rise in 4 weeks
2026-08-21Read Markup116.24-7.4% to today Distribution gives way to Markup with volume flow in agreement
2026-07-02Read Distribution117.35-8.2% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Allison Transmission Holdings, Inc. holds its Markdown at $107.67. The statistical read favours the buyers, held for 33 days.
As held on the ledger · 2026-10-27
Phase
Markdown · caution
Quantitative state
The statistical read favours the buyers, held for 33 days
Price at the screen
$107.67
Valuation
17.61 trailing · 9.84 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.98
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
47.52%
Below 33%
Interest-bearing debt is 47.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
30.06%
Below 49%
Money owed to the company is 30.1% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Allison Transmission Holdings,'s business is in a permissible area, but its interest-bearing debt is about 48% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ALSN's ethical verdict changes
Today ALSN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 56.7% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +25% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Heavy truck gears hide a cyclical trap
Every time a laden truck climbs a steep grade the gearbox has to deliver smooth power without fuss. Allison builds those transmissions for commercial fleets and US defence vehicles, and the numbers look attractive on paper. Revenue rose 84 percent, the firm earns a 15 percent profit margin and returns 30 percent on equity, all at a forward multiple of just 9.9 times. The ethical screen is clear and analysts still see modest upside to 136 dollars.
Yet the business sits squarely in a cyclical corner of auto parts. Low multiples on peak earnings are not a bargain, they are a warning that margins and volumes can fall sharply when fleet orders slow. The opportunity rating of none reflects that reality rather than any flaw in the product itself.
Currency swings, defence budget shifts and a sudden drop in freight demand could all compress those returns faster than the valuation suggests. We therefore pass.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ALSN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markdown$110.76+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown$110.76+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markdown$110.76-1.6%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$112.55+2.4%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
2026-10-12Markdown$109.86-5.5%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
2026-10-02Markdown · changed$116.28-8.4%Entry 8
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 9.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
2026-08-21Markup · changed$116.24+2.3%Entry 6
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
2026-07-21Distribution$113.60-3.2%Entry 5
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
2026-07-18Distribution$117.35+0.0%Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (10 analysts) rates it buy, with a mean price target of $137.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
